Cargando…

A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis

Infection with Epstein-Barr virus (EBV) and HLA-DRB1*1501-positivity is a risk factor for multiple sclerosis (MS), but whether an interaction between these two factors causes MS is unclear. We therefore conducted a meta-analysis on the effect of the interaction between HLA-DRB1*1501 and EBV infectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Di, Ye, Xingguang, Zhang, Na, Ou, Meiling, Guo, Congcong, Zhang, Baohuan, Liu, Yang, Wang, Man, Yang, Guang, Jing, Chunxia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676020/ https://www.ncbi.nlm.nih.gov/pubmed/26656273 http://dx.doi.org/10.1038/srep18083

Ejemplares similares

Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset
por: Bove, Riley, et al.
Publicado: (2016)

Chronic Cerebrospinal Vascular Insufficiency Is Not Associated with HLA DRB1*1501 Status in Multiple Sclerosis Patients
por: Weinstock-Guttman, Bianca, et al.
Publicado: (2011)

Multiple Sclerosis Risk Variant HLA-DRB1*1501 Associates with High Expression of DRB1 Gene in Different Human Populations
por: Alcina, Antonio, et al.
Publicado: (2012)

Association of HLA-DR2-Related Haplotype (HLA-DRB5*01-DRB1*1501-DQB1*0602) in Patients with Multiple Sclerosis in Khuzestan Province
por: DELFAN, Nooshin, et al.
Publicado: (2021)

Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D
por: Ramagopalan, Sreeram V., et al.
Publicado: (2009)

The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis
por: Xue, Jianmin, et al.
Publicado: (2011)

RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes
por: Bernardo, Lidice, et al.
Publicado: (2014)

Crystal Structure of HLA-DR2 (DRA*0101, DRB1*1501) Complexed with a Peptide from Human Myelin Basic Protein
por: Smith, Kathrine J., et al.
Publicado: (1998)

DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP)
por: Kaushansky, Nathali, et al.
Publicado: (2012)

HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
por: Brynedal, Boel, et al.
Publicado: (2007)

Epstein-Barr Virus and Multiple Sclerosis
por: Houen, Gunnar, et al.
Publicado: (2020)

Epstein–Barr virus and multiple sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2022)

HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis
por: Hoffmann, Steve, et al.
Publicado: (2008)

Epstein Barr virus infection and immune defense related to HLA‐DR15: consequences for multiple sclerosis
por: Olsson, Tomas
Publicado: (2020)

Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population
por: Xiao, Di, et al.
Publicado: (2016)

Polymorphism Located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 Haplotype Confer Susceptibility to CNS Hypersomnias (Essential Hypersomnia)
por: Miyagawa, Taku, et al.
Publicado: (2009)

Risk of Multiple Sclerosis in Epstein–Barr Virus Infection
por: Ahmed, Syed Ijlal, et al.
Publicado: (2019)

HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort
por: Gontika, Maria, et al.
Publicado: (2020)

Interactions between polymorphisms in the 3′untranslated region of the cyclin dependent kinase 6 gene and the human papillomavirus infection, and risk of cervical precancerous lesions
por: Ye, Xingguang, et al.
Publicado: (2017)

HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia
por: Cocco, Eleonora, et al.
Publicado: (2012)

Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population
por: Cocco, Eleonora, et al.
Publicado: (2013)

HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population
por: Toro, Jaime, et al.
Publicado: (2015)

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
por: Serafini, Barbara, et al.
Publicado: (2007)

The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
por: Pender, Michael P.
Publicado: (2011)

Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
por: Pender, Michael P, et al.
Publicado: (2014)

Smoking and Epstein–Barr virus infection in multiple sclerosis development
por: Hedström, Anna Karin, et al.
Publicado: (2020)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020)

Infection with Epstein Barr virus increases risk of multiple sclerosis
por: Barnes, Katharine
Publicado: (2022)

A role for the Epstein–Barr virus in multiple sclerosis aetiology?
por: Hrastelj, J., et al.
Publicado: (2022)

Epstein-Barr virus infection: the leading cause of multiple sclerosis
por: He, Ruirui, et al.
Publicado: (2022)

Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis
por: Debuysschere, Cyril, et al.
Publicado: (2023)

Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients
por: Jørgensen, Pernille B., et al.
Publicado: (2012)

HLA DRB101 and macrophagic myofasciitis
por: Guis, S, et al.
Publicado: (2003)

The importance of HLA DRB1 gene allele to clinical features and disability in patients with multiple sclerosis in Lithuania
por: Balnyte, Renata, et al.
Publicado: (2013)

Differential methylation at MHC in CD4(+) T cells is associated with multiple sclerosis independently of HLA-DRB1
por: Maltby, Vicki E., et al.
Publicado: (2017)

Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017)

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
por: Pender, Michael P., et al.
Publicado: (2020)

Epstein–Barr Virus and Multiple Sclerosis: Wrong Place, Wrong Time?
por: Maghzi, Amir-Hadi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5sgt5a0halhilqspgoauvi3pab